3.財務諸表及び主な注記

(1)貸借対照表

 

 

(単位:千円)

 

前事業年度

(2025年9月30日)

当事業年度

(2026年9月30日)

資産の部

 

 

流動資産

 

 

現金及び預金

2,170,097

1,423,894

売掛金

255,760

276,021

有価証券

1,000,000

1,000,000

仕掛品

21,521

20,630

原材料及び貯蔵品

28,228

26,776

前渡金

12,924

5,793

前払費用

85,479

29,478

その他

37,604

38,231

流動資産合計

3,611,617

2,820,827

固定資産

 

 

有形固定資産

 

 

建物(純額)

283,465

451,613

工具、器具及び備品(純額)

48,118

52,530

リース資産(純額)

3,554

2,644

建設仮勘定

21,482

21,482

有形固定資産合計

356,621

528,271

無形固定資産

 

 

特許権

12,291

18,750

ソフトウエア

38,434

37,643

ソフトウエア仮勘定

17,261

57,702

無形固定資産合計

67,987

114,096

投資その他の資産

 

 

投資有価証券

154,550

55,877

長期貸付金

459,250

423,250

破産更生債権等

23,468

23,468

長期前払費用

1,285

853

差入保証金

62,007

60,539

貸倒引当金

△482,718

△446,718

投資その他の資産合計

217,843

117,269

固定資産合計

642,452

759,638

資産合計

4,254,070

3,580,465

 

 

 

 

(単位:千円)

 

前事業年度

(2025年9月30日)

当事業年度

(2026年9月30日)

負債の部

 

 

流動負債

 

 

買掛金

41,074

56,793

未払金

77,452

116,331

未払費用

9,304

9,065

未払法人税等

10,507

11,892

預り金

6,969

6,220

賞与引当金

72,176

66,336

株式報酬引当金

-

1,573

その他

15,625

-

流動負債合計

233,110

268,213

固定負債

 

 

繰延税金負債

15,458

-

資産除去債務

162,195

387,113

株式報酬引当金

65,646

15,721

その他

88

963

固定負債合計

243,387

403,799

負債合計

476,497

672,012

純資産の部

 

 

株主資本

 

 

資本金

5,102,250

4,023,940

資本剰余金

 

 

資本準備金

3,850

279,978

資本剰余金合計

3,850

279,978

利益剰余金

 

 

その他利益剰余金

 

 

繰越利益剰余金

△1,362,138

△1,397,804

利益剰余金合計

△1,362,138

△1,397,804

自己株式

△4

△6

株主資本合計

3,743,957

2,906,107

評価・換算差額等

 

 

その他有価証券評価差額金

33,615

△6,044

評価・換算差額等合計

33,615

△6,044

新株予約権

-

8,389

純資産合計

3,777,572

2,908,452

負債純資産合計

4,254,070

3,580,465

 

E0535123700株式会社メディネットMEDINET Co., Ltd.通期第2号参考様式 [日本基準](非連結)Japan GAAPfalseCTE2025-10-012026-09-30FY2026-09-302024-10-012025-09-302025-09-301falsefalsefalse237002024-10-012025-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:ContractedCellManufacturingBusinessReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:CellularAndTissueBasedProductBusinessReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReconcilingItemsMember237002024-10-012025-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember237002024-10-012025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:LegalCapitalSurplusMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsBroughtForwardMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002025-10-012026-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002025-10-012026-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002025-10-012026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002026-09-30jppfs_cor:NonConsolidatedMember237002026-11-13237002025-10-012026-09-30237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002025-10-012026-09-30jppfs_cor:TreasuryStockMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:ContractedCellManufacturingBusinessReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:CellularAndTissueBasedProductBusinessReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReconcilingItemsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember237002024-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsBroughtForwardMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:UnallocatedAmountsAndEliminationMemberxbrli:pureiso4217:JPY